Written Opinion of the International Search Authority, page-6

Further.....

ASX NOX ann of 23 nov 2106. “NOX66 was designed to keep idronoxil circulating in the body in an active form that readily sought out cancer cells. It appears that this design fortuitously also allows free and ready access of this drug to the brain,” Kelly added. The release of this news corresponds with the lodgement yesterday of an appropriate patent for this intellectual property. "

That IO patent filled on the 22of Nov 2016 is now two weeks past it 12-month provisional allowance to which a new publication most likely will tell us what has replaced it to keep its priority date. This patent has also been tied to the international patents listed under noxopharm with patentscope.